+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sangamo Therapeutics Inc - logo

Sangamo BioSciences is a biotechnology company that develops industry leading technologies in gene therapy, genome editing, cell therapy and gene regulation. The company is focused on pioneering genetic cures for monogenic and infectious diseases by deploying its AAV-based gene therapy platform, and therapeutic genome editing and gene regulation platforms based on its novel zinc finger DNA-binding protein technology. Sangamo is headquartered in Richmond, California.

From
Fabry Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Fabry Disease Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 367 Pages
  • Global
From
Hunter Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Hunter Syndrome Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 280 Pages
  • Global
From
Fabry Disease Drugs Market 2024-2028 - Product Thumbnail Image

Fabry Disease Drugs Market 2024-2028

  • Report
  • January 2024
  • 149 Pages
  • Global
From
End-Stage Renal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

End-Stage Renal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Addiction Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Addiction Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Mucopolysaccharidosis Treatment Market Report 2025 - Product Thumbnail Image

Mucopolysaccharidosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Mucopolysaccharidosis II - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis II - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis I - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis I - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator